冲击指数是一个更强大的预测结果在老年人比年轻患者的结果
Aryan Rafieezadeh1, Kartik Prabhakaran1, Jordan Kirsch1
1Westchester Medical Center, New York Medical College, Valhalla, New York.
The Journal of surgical research
|May 24, 2024
概括
冲击指数 (SI) 预测创伤结果,但在老年患者中较低. 与年轻的创伤患者相比,这个指数是老年人死亡率和干预措施的更强有力的预测指标.
科学领域:
- 创伤护理的护理人员.
- 老年医学 老年医学
- 临床结果研究研究的临床结果.
背景情况:
- 冲击指数 (SI) 是创伤患者不良结果的公认预测指标.
- 关于SI在不同年龄组的预测值的有限的比较数据存在,特别是在老年人群中.
研究的目的:
- 为了比较老年和年轻成人创伤患者之间的冲击指数 (SI) 值.
- 评估SI对死亡率,输血和各年龄组重大手术干预的预测性能.
主要方法:
- 对创伤质量改善计划数据库 (2017-2019) 的回顾性分析.
- 纳入标准:患者年龄≥25岁,伤害严重性评分≥16.
- 年龄组:25-44岁,45-64岁,65岁以上. 计算SI,并分析结果 (死亡率,输血,重大手术).
主要成果:
- 总共分析了244,943名患者. 最年轻组的SI值最高 (0.82 ± 0.33),老年组的SI值最低 (0.62 ± 0.30).
- 在老年人群中死亡率最高 (17%) 与年轻人群 (9.7%和11.3%) 相比.
- 在老年病学中,每增加0.1的SI显著与更高的死亡率相关 (OR=1.126),输血 (OR=1.318) 和重大手术 (OR=1.648). 在老年医学中,SI对输血和重大手术的预测准确度更高.
结论:
- 冲击指数 (SI) 是严重创伤结果的重要预测指标,特别是在老年患者中.
- 与年轻人相比,SI对老年人的不良结果具有更强的预测能力,这突显了它在这个人口群体中的临床实用性.
更多相关视频
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
01:24Blood Pressure Imbalances and Circulatory Shock
769
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
769
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:28Special considerations while measuring blood pressure
719
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
719